首页> 外国专利> 6-Piperazino morphanthridine hydrogen maleate - prepd. from 6-chloro-morphanthridine with piperazine in xylene, and having sedative and hypnotic activity

6-Piperazino morphanthridine hydrogen maleate - prepd. from 6-chloro-morphanthridine with piperazine in xylene, and having sedative and hypnotic activity

机译:6-Piperazino吗啡马来酸氢甲酯-制备。由6-氯吗啡啶与哌嗪在二甲苯中合成,具有镇静和催眠作用

摘要

6-Piperazinomoprhanthridine hydrogen maleate (I) is new. The cpd. is prepd. in pure crystalline form by reaction of 6-chloromorphanthridine with piperazine in xylene to give the free base, then treating the crude base in acetone with maleic acid. The salt is isolated by adding ether. Oral doses of 1.25-5 mg./kg. in the rat cause increases slow-wave sleep markedly only in the first three hrs. whereas the duration of paradoxal sleep hardly varies or increases slightly between the 2nd and 7th hrs. Perfusion of 18.7 mg./kg. i.v. does not significantly affect blood pressure. It does not induce sec. extra-pyramidal effects or neurological effects after 64 mg./kg. orally. The oral LD50 is 1000 mg./kg.
机译:6-哌嗪酮基氨基吡啶马来酸氢盐(I)是新的。 cpd。准备好了。通过使6-氯吗啡啶与哌嗪在二甲苯中反应得到纯碱,得到游离碱,然后用马来酸在丙酮中处理粗碱。通过添加醚分离盐。口服剂量为1.25-5 mg./kg。仅在头三个小时,大鼠中的慢波睡眠才明显增加。而悖论性睡眠的时间在第二和第七小时之间几乎没有变化或略有增加。 18.7 mg./kg的灌注量。 i.v.不会显着影响血压。它不会引起秒。 64 mg./kg后出现锥体束外作用或神经系统作用。口头。口服LD50> 1000 mg./kg。

著录项

  • 公开/公告号FR2405253A1

    专利类型

  • 公开/公告日1979-05-04

    原文格式PDF

  • 申请/专利权人 SANDOZ SA;

    申请/专利号FR19770029746

  • 发明设计人 HORST KLEINLOGEL;

    申请日1977-10-04

  • 分类号C07D403/04;A61K31/55;

  • 国家 FR

  • 入库时间 2022-08-22 19:32:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号